News

But maybe Edgar to start with you and with your expertise in the condition of autosomal dominant polycystic kidney disease, ...
The current standard of care for the definition, classification, and prognosis of chronic kidney disease, defined by the Kidney Disease Improving Global Outcomes (KDIGO) guidelines—the estimated ...
SGLT2 inhibitors significantly improve hemoglobin and hematocrit levels in CKD patients, enhancing anemia management. The KDIGO 2024 guideline endorses SGLT2 inhibitors for CKD patients ...